Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-11

Clinical Trial Update: Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets

View source ↗

Summary

Post-marketing surveillance study assessing the safety and efficacy of Champix (varenicline) tablets for smoking cessation; the study is completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Champix (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Status: COMPLETED | Results posted: 2012-05-11